Pricing Log in Create free account

NovoCure Limited (NVCR) vs UFP Technologies, Inc. (UFPT)

NovoCure Limited and UFP Technologies, Inc. are both Medical Devices companies. UFP Technologies, Inc. is the larger, with a market value of $2.3B against $1.7B — 1.4× the size. NovoCure Limited has negative trailing earnings, so its P/E is not meaningful; UFP Technologies, Inc. trades at 31.2×. NovoCure Limited grew revenue faster over the last twelve months: 11.0% against 7.32%. UFP Technologies, Inc. has the higher net margin (11.5% vs −21.3%) and the higher return on invested capital (10.3% vs −115.6%). Across the 19 metrics below, UFP Technologies, Inc. leads on 13 and NovoCure Limited on 6.

Valuation

Metric NVCR UFPT Medical Devices median
P/E n/m 31.16 23.22
P/S 2.33 3.57 2.34
P/B 4.83 4.88 2.33
Price to free cash flow n/m 36.71 23.72
EV/EBITDA n/m 20.52 11.54
EV/Sales 1.97 3.77 2.24
Earnings yield (9.24%) 3.21% (10.09%)
Free cash flow yield (1.56%) 2.72% (8.47%)

Profitability

Metric NVCR UFPT Medical Devices median
Gross margin 76.13% 28.50% 56.01%
Operating margin (22.08%) 15.25% (15.03%)
Net margin (21.25%) 11.45% (20.40%)
Free cash flow margin (3.64%) 9.74% (7.24%)
Return on equity (43.22%) 17.05% (15.32%)
Return on assets (14.56%) 10.98% (19.72%)
Return on invested capital (115.56%) 10.29% (10.33%)

Growth

Metric NVCR UFPT Medical Devices median
Revenue growth (TTM) 10.95% 7.32% 8.80%
EPS growth (last fiscal year) 21.79% 15.44% 29.03%
Revenue growth, 5-year CAGR 5.80% 27.43% 15.47%
Net income growth, 5-year CAGR 0.00% 38.57% 0.00%

Health

Metric NVCR UFPT Medical Devices median
Debt to equity 0.58 0.28 0.07
Current ratio 2.89 3.00 2.50
Net debt to EBITDA 1.36 1.16 0.49

Dividend

Metric NVCR UFPT Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric NVCR UFPT Medical Devices median
Market cap 1.68b 2.30b 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack